Tag: Prostate Conditions

Researchers at Case Western Reserve University and University Hospitals Case Medical Center have assessed the impact of the 2012 U.S. Preventive Services Task Force (USPSTF) recommendations against routine prostate specific antigen (PSA) cancer screenings. The 2012 report cited evidence that the risks of screening outweigh the benefits. Results of the current study indicate that the USPSTF recommendations have resulted in a decrease in the number of PSA screenings ordered by doctors, with the greatest decline seen among urologists.

Prostate-cancer patients who have robotic-assisted surgery have less need for treatments such as hormone or radiation therapy, according to a new study.

Researchers from UCLA's Jonsson Comprehensive Cancer Center also found that the robotic-assisted surgery left fewer instances of cancer cells at the edge of the surgical specimen.

The study, published in the journal European Urology, was led by Dr. Jim Hu, director of robotic and minimally invasive surgery in the urology department at the David Geffen School of Medicine at UCLA.

Dormant prostate-cancer cells in bone tissue can be reawakened, causing the disease to spread to different parts of the body.

The discovery, by researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, in Los Angeles, could lead to new ways to intervene before the disease progresses.

A powerful new animal model for metastatic prostate cancer known as RapidCaP reveals a cancer-gene 'switch' that drives metastasis. That is the finding of research done at Cold Spring Harbor Laboratory on Long Island in New York. The study was published on January 24^th 2014 in the journal Cancer Discovery.

If the man in your life has been prescribed androgen deprivation therapy (ADT) as part of the treatment for prostate cancer, you’re both best off if you’re warned ahead of time about possible side-effects and offered advice about coping strategies.

Lower levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest an increased risk for developing advanced prostate cancer, according to findings presented in San Diego at the American Association for Cancer Research Conference held January 18^th to 21^st 2014.

A research group at Biocenter Oulu in Finland has identified a mechanism that initiates a genetic program that ups the risk of prostate cancer metastasis. The study was published in the journal Nature Genetics in January 2014.

A release from the Academy of Finland notes that prostate cancer is the most commonly diagnosed malignancy and the second most common cause of cancer-related deaths in men worldwide.

Use of a “nomogram,” – a calculating device for prediction – can estimate individual risks that a screen-detected prostate cancer has been overdiagnosed, according to a study done at the Fred Hutchinson Cancer Research Center in Seattle and published January 6th 2014 in the Journal of the National Cancer Institute.